The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Open accessAbstract
Significance: HIV infection cannot be cured by current antiretroviral drugs, due to the presence of long-lived latently infected cells. New antilatency drugs are being tested in clinical trials, but major unknowns remain. It is unclear how much latent virus must be eliminated for a cure, which remains difficult to answer empirically due to few case studies and limited sensitivity of viral reservoir assays. In this paper, we introduce a mathematical model of HIV dynamics to calculate the likelihood and timing of viral rebound following antilatency treatment. We derive predictions for the required efficacy of antilatency drugs, and demonstrate that rebound times may be highly variable and occur after years of remission. These results will aid in designing and interpreting HIV cure studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A First Course in Stochastic Processes
(1975) · Elsevier eBooks · doi:10.1016/c2009-1-28569-8 · Cited by 3,890
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Self-citationRecovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186 · cited 3×
“PLoS Comput Biol 7(4), e1002033 (2011).”
BackgroundInfluentialQuantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · cited 4×
“Annu Rev Pharmacol Toxicol 51(1):397–418.”
BackgroundInfluentialSelf-citationPresence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Self-citationDecay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müßig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802905 · Cited by 1,837
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Self-citationReplication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Self-citationAdministration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011
Virus dynamics: Mathematical principles of immunology and virology
Nowak, M. A., & May, R. M. (2001) · Cited by 934
Self-citationChun, T.-W., Engel, D., Berrey, M. M., Shea, T., Corey, L., & Fauci, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8869 · Cited by 846
Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy
Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A. S., Korber, B. T., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402101 · Cited by 807
Fletcher, C. V., Staskus, K., Wietgrefe, S. W., Rothenberger, M., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 664
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T.-W., Strain, M., Richman, D., & Luzuriaga, K. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302976 · Cited by 581
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Eriksson, S., Graf, E. H., Dahl, V., Strain, M. C., Yukl, S. A., Lysenko, E. S., Bosch, R. J., Lai, J., Chioma, S., Emad, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003174 · Cited by 567
Self-citationCell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
Sigal, A., Kim, J. T., Balazs, A. B., Dekel, E., Mayo, A., Milo, R., & Baltimore, D. (2011) · Nature · doi:10.1038/nature10347 · Cited by 537
Bullen, C. K., Laird, G. M., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2014) · Nature Medicine · doi:10.1038/nm.3489 · Cited by 488
Self-citationDinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
Self-citationHIV-1 persistence in CD4+ T cells with stem cell–like properties
Buzon, M. J., Sun, H., Li, C., Shaw, A., Seiss, K., Ouyang, Z., Martin-Gayo, E., Leng, J., Henrich, T. J., Li, J. Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3445 · Cited by 414
Henrich, T. J., Hanhauser, E., Marty, F. M., Sirignano, M. N., Keating, S., Lee, T.-H., Robles, Y. P., Davis, B. T., Li, J. Z., Heisey, A., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-1027 · Cited by 401
Self-citationMarkowitz, M., Louie, M., Hurley, A., Sun, E., Di Mascio, M., Perelson, A. S., & Ho, D. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.5037-5038.2003 · Cited by 399
Strain, M. C., Little, S. J., Daar, E. S., Havlir, D. V., Günthard, H. F., Lam, R. Y., Daly, O. A., Nguyen, J., Ignacio, C. C., Spina, C. A., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428777 · Cited by 331
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
Shen, L., Peterson, S., Sedaghat, A. R., McMahon, M. A., Callender, M., Zhang, H., Zhou, Y., Pitt, E., Anderson, K. S., Acosta, E. P., et al. (2008) · Nature Medicine · doi:10.1038/nm1777 · Cited by 327
Self-citationAn Integrated Overview of HIV-1 Latency
Ruelas, D. S., & Greene, W. C. (2013) · Cell · doi:10.1016/j.cell.2013.09.044 · Cited by 324
Prostratin Antagonizes HIV Latency by Activating NF-κB
Williams, S. A., Chen, L.-F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402124200 · Cited by 318
Gandhi, R. T., Zheng, L., Bosch, R. J., Chan, E. S., Margolis, D. M., Read, S., Kallungal, B., Palmer, S., Medvik, K., Lederman, M. M., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000321 · Cited by 304
HIV rebounds from latently infected cells, rather than from continuing low-level replication
Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Böni, J., Hirschel, B., Weber, R., Trkola, A., Günthard, H. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804192105 · Cited by 294
Yukl, S. A., Boritz, E., Busch, M., Bentsen, C., Chun, T.-W., Douek, D., Eisele, E., Haase, A., Ho, Y.-C., Hütter, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003347 · Cited by 291
Self-citationChun, T.-W., Justement, J. S., Murray, D., Hallahan, C. W., Maenza, J., Collier, A. C., Sheth, P. M., Kaul, R., Ostrowski, M., Moir, S., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328340a239 · Cited by 276
Reactivation of Latent HIV-1 by Inhibition of BRD4
Zhu, J., Gaiha, G. D., John, S. P., Pertel, T., Chin, C. R., Gao, G., Qu, H., Walker, B. D., Elledge, S. J., & Brass, A. L. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.008 · Cited by 244
Ribeiro, R. M., Qin, L., Chavez, L. L., Li, D., Self, S. G., & Perelson, A. S. (2010) · Journal of Virology · doi:10.1128/jvi.00127-10 · Cited by 238
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Boehm, D., Calvanese, V., Dar, R. D., Xing, S., Schroeder, S., Martins, L., Aull, K., Li, P.-C., Planelles, V., Bradner, J. E., et al. (2013) · Cell Cycle · doi:10.4161/cc.23309 · Cited by 235
Self-citationCillo, A. R., Sobolewski, M. D., Bosch, R. J., Fyne, E., Piatak, M., Coffin, J. M., & Mellors, J. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402873111 · Cited by 232
Mehla, R., Bivalkar-Mehla, S., Zhang, R., Handy, I., Albrecht, H., Giri, S., Nagarkatti, P., Nagarkatti, M., & Chauhan, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011160 · Cited by 227
Do most lymphocytes in humans really reside in the gut?
Ganusov, V. V., & De Boer, R. J. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.08.009 · Cited by 224
Archin, N. M., Vaidya, N. K., Kuruc, J. D., Liberty, A. L., Wiegand, A., Kearney, M. F., Cohen, M. S., Coffin, J. M., Bosch, R. J., Gay, C. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120248109 · Cited by 221
Reactivation of latent HIV by histone deacetylase inhibitors
Shirakawa, K., Chavez, L., Hakre, S., Calvanese, V., & Verdin, E. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.02.005 · Cited by 217
Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency
Korin, Y. D., Brooks, D. G., Brown, S., Korotzer, A., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8118-8123.2002 · Cited by 208
Kieffer, T. L., Finucane, M. M., Nettles, R. E., Quinn, T. C., Broman, K. W., Ray, S. C., Persaud, D., & Siliciano, R. F. (2004) · The Journal of Infectious Diseases · doi:10.1086/382488 · Cited by 201
Self-citationSpivak, A. M., Andrade, A., Eisele, E., Hoh, R., Bacchetti, P., Bumpus, N. N., Emad, F., Buckheit, R., McCance-Katz, E. F., Lai, J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit813 · Cited by 200
Self-citationBartholomeeusen, K., Xiang, Y., Fujinaga, K., & Peterlin, B. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410746 · Cited by 197
Xing, S., Bullen, C. K., Shroff, N. S., Shan, L., Yang, H.-C., Manucci, J. L., Bhat, S., Zhang, H., Margolick, J. B., Quinn, T. C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02033-10 · Cited by 197
Self-citationAntiretroviral dynamics determines HIV evolution and predicts therapy outcome
Rosenbloom, D. I. S., Hill, A. L., Rabi, S. A., Siliciano, R. F., & Nowak, M. A. (2012) · Nature Medicine · doi:10.1038/nm.2892 · Cited by 189
Self-citationDetermination of virus burst size in vivo using a single-cycle SIV in rhesus macaques
Chen, H. Y., Mascio, M. D., Perelson, A. S., Ho, D. D., & Zhang, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707449104 · Cited by 179
A quantitative basis for antiretroviral therapy for HIV-1 infection
Jilek, B. L., Zarr, M., Sampah, M. E., Rabi, S. A., Bullen, C. K., Lai, J., Shen, L., & Siliciano, R. F. (2012) · Nature Medicine · doi:10.1038/nm.2649 · Cited by 165
Self-citationDeChristopher, B. A., Loy, B. A., Marsden, M. D., Schrier, A. J., Zack, J. A., & Wender, P. A. (2012) · Nature Chemistry · doi:10.1038/nchem.1395 · Cited by 161
Archin, N. M., Cheema, M., Parker, D., Wiegand, A. P., Bosch, R. J., Coffin, J. M., Eron, J. J., Cohen, M. S., & Margolis, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009390 · Cited by 160
Stochastic gene expression as a molecular switch for viral latency
Singh, A., & Weinberger, L. S. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.06.016 · Cited by 153
Loss and Recovery of Genetic Diversity in Adapting Populations of HIV
Pennings, P. S., Kryazhimskiy, S., & Wakeley, J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004000 · Cited by 147
Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions
Pearson, J. E., Krapivsky, P. L., & Perelson, A. S. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001058 · Cited by 145
Epigenetic regulation of HIV latency
Hakre, S., Chávez, L., Shirakawa, K., & Verdin, E. M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283412384 · Cited by 125
Stochastic or deterministic: what is the effective population size of HIV-1?
Kouyos, R. D., Althaus, C. L., & Bonhoeffer, S. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.10.001 · Cited by 124
Linkage disequilibrium test implies a large effective population number for HIV in vivo
Rouzine, I. M., & Coffin, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10758 · Cited by 123
Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
Karn, J., & Mbonye, U. R. (2011) · Current HIV Research · doi:10.2174/157016211798998736 · Cited by 107
Developing strategies for HIV-1 eradication
Durand, C. M., Blankson, J. N., & Siliciano, R. F. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.001 · Cited by 103
Self-citationStanding Genetic Variation and the Evolution of Drug Resistance in HIV
Pennings, P. S. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002527 · Cited by 102
Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues
de Boer, R. J., Ribeiro, R. M., & Perelson, A. S. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000906 · Cited by 95
Stöhr, W., Fidler, S. J., McClure, M. O., Weber, J. N., Cooper, D. A., Ramjee, G., Kaleebu, P., Tambussi, G., Schechter, M., Babiker, A. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078287 · Cited by 94
Conway, J. M., & Coombs, D. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002033 · Cited by 89
Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency
Choudhary, S. K., & Margolis, D. M. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100237 · Cited by 89
Luo, R., Piovoso, M. J., Martínez‐Picado, J., & Zurakowski, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040198 · Cited by 84
Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
Sedaghat, A. R., Siliciano, J. D., Brennan, T. P., Wilke, C. O., & Siliciano, R. F. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030122 · Cited by 80
Self-citationMascio, M. D., Paik, C. H., Carrasquillo, J. A., Maeng, J., Jang, B., Shin, I. S., Srinivasula, S., Byrum, R., Neria, A., Kopp, W., et al. (2009) · Blood · doi:10.1182/blood-2008-12-192203 · Cited by 58
Modelling HIV-1 2-LTR dynamics following raltegravir intensification
Luo, R., Ojeda, E. F. C., Piovoso, M. J., Wu, H., Buzón, M. J., Martínez‐Picado, J., & Zurakowski, R. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0186 · Cited by 43
Establishment and Maintenance of HIV Latency: Model Systems and Opportunities for Intervention
Marsden, M. D., & Zack, J. A. (2009) · Future Virology · doi:10.2217/fvl.09.70 · Cited by 32
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Kearney, M. F., Kashuba, A. D., Liberty, A. L., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/18v5-mv62 · Cited by 28
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
Ojeda, E. F. C., Luo, R., Piovoso, M. J., & Zurakowski, R. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.12.020 · Cited by 19
The Effect of Early Treatment on the Latent Reservoir of HIV‐1
Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/428783 · Cited by 6
Self-citation
Cited by
HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment
Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., Mankowski, J. L., Brown, A., Volsky, D. J., & McArthur, J. C. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.27 · Cited by 1,036
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Crooks, A. M., Bateson, R., Cope, A. B., Dahl, N. P., Griggs, M. K., Kuruc, J. D., Gay, C. L., Eron, J. J., Margolis, D. M., Bosch, R. J., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv218 · Cited by 406
Targeting the Latent Reservoir for HIV-1
Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 340
Self-citationThe RV411 study group, Colby, D. J., Trautmann, L., Pinyakorn, S., Leyre, L., Pagliuzza, A., Kroon, E., Rolland, M., Takata, H., Buranapraditkun, S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0026-6 · Cited by 331
Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.
Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508952 · Cited by 283
Metadata
- Authors
- Hill, A. L., Rosenbloom, D. I. S., Fu, F., Nowak, M. A., & Siliciano, R. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-08-05
- Volume
- 111
- Issue
- 37
- Pages
- 13475-13480
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1980223851
- Cited by
- 265
- References
- 71
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.